ORASURE TECHNOLOGIES, INC Other Comprehensive Income (Loss), Net of Tax
ORASURE TECHNOLOGIES, INC (OSUR) reported Other Comprehensive Income (Loss), Net of Tax of $3.88 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2023-08-04
- ORASURE TECHNOLOGIES, INC other comprehensive income (loss), net of tax for the quarter ending 2023-06-30 was $2.86M.
- ORASURE TECHNOLOGIES, INC other comprehensive income (loss), net of tax for the quarter ending 2023-03-31 was $1.02M.
- ORASURE TECHNOLOGIES, INC other comprehensive income (loss), net of tax for the quarter ending 2012-09-30 was $1.49M.
- ORASURE TECHNOLOGIES, INC other comprehensive income (loss), net of tax for the quarter ending 2012-06-30 was -$859.35K, a 50531.46% decline year-over-year.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month |
|---|---|---|---|
| 2023-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $3.88M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.02M 10-Q · filed 2023-05-10 | ||
| 2012-09-30 | $1.49M 10-Q · filed 2012-11-09 | $626.46K derived: sum of 2 quarters · filed 2012-11-09 | $1.73M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$859.35K 10-Q · filed 2012-08-08 | $246.24K 10-Q · filed 2012-08-08 | |
| 2011-09-30 | -$2.83M 10-Q · filed 2012-11-09 | -$2.83M derived: sum of 2 quarters · filed 2012-11-09 | -$2.83M 10-Q · filed 2012-11-09 |
| 2011-06-30 | $1.70K 10-Q · filed 2012-08-08 | $1.44K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |